You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PEG-rhG-CSF

Showing 1 - 25 of 2,545
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in Chongqing (PEG-rhG-CSF, RhG-CSF)

Recruiting
  • Lymphoma
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Aug 31, 2023

Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

Not yet recruiting
  • Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 18, 2023

Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • pegylated recombinant human granulocyte-colony stimulating factor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Sep 23, 2023

Breast Cancer Female Trial in Shanghai (MW05, PEG-rhG-CSF)

Completed
  • Breast Cancer Female
  • Shanghai, China
    Fudan University Affiliated Cancer Hospital
Dec 1, 2022

Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Hematological Malignancy
  • Ningbo, Zhejiang, China
    The Affiliated People's Hospital of Ningbo University.
Aug 18, 2022

Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

Not yet recruiting
  • Granulocyte Colony-stimulating Factor
  • Stem Cell Mobilization
  • PEG-rhG-CSF
  • (no location specified)
Jun 13, 2022

Lymphoma Trial (PEG-rhG-CSF, rhG-CSF)

Not yet recruiting
  • Lymphoma
  • (no location specified)
Dec 13, 2021

Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • Hangzhou, Zhejiang, China
  • +6 more
Sep 7, 2022

Granulocyte Colony-Stimulating Factor Trial in Wuhan (PEG-rhG-CSF, G-CSF)

Not yet recruiting
  • Granulocyte Colony-Stimulating Factor
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

Granulocyte Colony-Stimulating Factor, PD-1 Inhibitor Trial in Guangzhou (PEG-rhG-CSF)

Recruiting
  • Granulocyte Colony-Stimulating Factor
  • PD-1 Inhibitor
  • PEG-rhG-CSF
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022

Non-Myeloid Malignancy Trial in Beijing (YPEG-rhG-CSF, rhG-CSF/PEG-rhG-CSF)

Completed
  • Non-Myeloid Malignancy
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Feb 7, 2022

Pediatric Cancer Trial in Guangzhou (pegylated recombinant human granulocyte-colony stimulating factor)

Recruiting
  • Pediatric Cancer
  • pegylated recombinant human granulocyte-colony stimulating factor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center,
Aug 27, 2021

Breast Cancer Trial in Nanjing (Day 7 regimen, Day 3 regimen)

Recruiting
  • Breast Cancer
  • Day 7 regimen
  • Day 3 regimen
  • Nanjing, Jiangsu, China
    the First Affiliated Hospital of Nanjing Medical University
Jul 17, 2021

PD-1 Inhibitor, G-CSF Trial in Guangzhou (Camrelizumab, G-CSF)

Recruiting
  • PD-1 Inhibitor
  • G-CSF
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022

Gynecologic Malignant Tumor Trial in Shanghai (Mecapegfilgrastim Injection)

Not yet recruiting
  • Gynecologic Malignant Tumor
  • Mecapegfilgrastim Injection
  • Shanghai, Shanghai, China
    No. 270, Dongan Road, Xuhui District, Shanghai, China
Feb 24, 2021

Cervical Cancer Trial in Chongqing (PEG-rhG-CSF, rhG-CSF)

Unknown status
  • Cervical Cancer
  • Chongqing, Chongqing, China
    Chongqing Cancer Hospital
Sep 2, 2020

Breast Cancer, Neutropenia Trial in Beijing (PEG-rhG-CSF)

Completed
  • Breast Cancer
  • Neutropenia
  • PEG-rhG-CSF
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 26, 2020

Hemophagocytic Syndrome Trial in Beijing (PEG-rhG-CSF, rhG-CSF)

Not yet recruiting
  • Hemophagocytic Syndrome
  • Beijing, China
    Beijing Friendship Hospital
Aug 3, 2020

Non Hodgkin's Lymphoma Trial in Shijiazhuang (PEG-rhG-CSF)

Unknown status
  • Non Hodgkin's Lymphoma
  • PEG-rhG-CSF
  • Shijiazhuang, Hebei, China
    The fourth hospital of Hebei Medical University
Aug 2, 2020

Lymphoma, Leukemia Trial in Shanghai (PEG-rhG-CSF group, rhG-CSF group)

Unknown status
  • Lymphoma
  • Leukemia
  • PEG-rhG-CSF group
  • rhG-CSF group
  • Shanghai, China
    Children's Hospital of Fudan University
Aug 2, 2020

Lymphoma, Non-Hodgkin, Granulocyte Colony-Stimulating Factor, Cost-Benefit Analysis Trial in Shanghai (PEG-rhG-CSF, rhG-CSF)

Unknown status
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin hospital
Sep 5, 2019

Advanced Pancreatic Cancer Trial in Beijing (PEG-rhG-CSF)

Unknown status
  • Advanced Pancreatic Cancer
  • PEG-rhG-CSF
  • Beijing, China
    Chinese PLA General Hospital First medical center
Jan 20, 2020

Localized Breast Cancer Trial in Dijon (Dense dose epirubicin-cyclophosphamide chemo and G-CSF (filgrastim, lenograstim), Dense

Not yet recruiting
  • Localized Breast Cancer
  • Dense dose epirubicin-cyclophosphamide chemotherapy and G-CSF (filgrastim, lenograstim)
  • Dense dose epirubicin-cyclophosphamide chemotherapy with administration of peg-G-CSF (pegfilgrastim)
  • Dijon, Bourgogne, France
    Centre Georges François Leclerc (CGFL)
Mar 24, 2022

PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia

Unknown status
  • Chemotherapy-induced Neutropenia
  • Myelosuppression
  • PEG-rhG-CSF
  • (no location specified)
Feb 18, 2019

Adjuvant Chemo, Ovarian Tumors, Ovarian Cancer Trial in Jinan (PEG-rhG-CSF)

Unknown status
  • Adjuvant Chemotherapy
  • +2 more
  • PEG-rhG-CSF
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Feb 27, 2019